A Plea to FDA and EMA: Remove Barriers to Approving Type 1 Diabetes Treatments

A published article in Diabetes Care argues for the reestablishment of C‑peptide as a recognized primary endpoint for the full approval of type 1 diabetes therapies.

HARPERS FERRY, WV, UNITED STATES, April 22, 2026 /EINPresswire.com/ — The prominent journal Diabetes Care has released “The Importance of C‑Peptide for Developing T1D Disease‑Modifying Therapies,” authored by G. Alexander Fleming (Kinexum), Chantal Mathieu (UZ Leuven), and Jay Skyler (Diabetes Research Institute, University of Miami). The article presents a scientific and regulatory argument for bringing back C‑peptide as a primary endpoint for the full approval of disease-modifying therapies (DMTs) for type 1 diabetes (T1D).

The absence of this regulatory measure negatively affects the development of DMTs. Traditional glycemic endpoints such as HbA1c, and the risks of hypoglycemia and diabetic complications, take years to show changes after a T1D diagnosis in well-managed patients. Trials that show benefits in these outcomes need to last many years. The extended time and costs of such trials deter investors and small companies. The lack of approved treatments for newly diagnosed T1D is mainly due to the challenges of the disorder, but regulatory burdens also contribute to this need remaining unfulfilled. Without C‑peptide as an accepted endpoint, potential Disease‑Modifying Therapy (DMT) candidates undergo trials that are unnecessarily long, large, and costly—and some cannot progress at all. Reinstating C‑peptide as an approvable endpoint could not only speed up current programs but also facilitate the quicker development of treatment combinations, which may be needed to achieve curative approaches.

The main argument is clear. C‑peptide, co-secreted with insulin by the pancreatic beta cells destroyed in T1D, is a validated measure of remaining insulin secretion from the pancreas—better than insulin measurements themselves. Decades of evidence indicate that maintaining even low levels of C‑peptide significantly reduces hypoglycemia, improves glycemic control, and decreases long-term complication rates. The FDA used to accept C‑peptide as a clinical trial endpoint for full approval of T1D therapies aimed at preserving or restoring insulin secretion. That acceptance was once part of the FDA’s diabetes guidance. It was recently withdrawn—not due to doubts about C‑peptide’s validity or external expert opinions, but due to a broader requirement for more stringent validation trials. However, the scientific support for C‑peptide has only increased, and expert agreement continues to solidify.

Drs. Fleming, Mathieu, and Skyler bring together over a century of expertise in T1D research and drug development. Drs. Mathieu and Skyler have led key T1D trials and have served as Presidents of the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA), respectively. Dr. Fleming, formerly responsible for diabetes drug review at the FDA, has been a long-time advisor to many programs in the T1D field. He founded Kinexum in 2003, focusing on R&D in the cardiometabolic area, especially T1D.

The authors will participate in a webinar sponsored by The Kitalys Institute in June, discussing potential therapeutic and technological solutions for T1D. Details will be available soon on The Kitalys Institute website.

Key points:

• C‑peptide directly measures beta cell function—the loss of which defines T1D

• Its clinical value is backed by decades of evidence

• The FDA once accepted C‑peptide as an endpoint; this acceptance was withdrawn without scientific justification

• Current endpoint requirements block a whole category of promising DMTs

• Reinstating it could shorten timelines, lower costs, and expand treatment options for millions of patients

“The Importance of C‑Peptide for Developing T1D Disease‑Modifying Therapies” is published in Diabetes Care at https://doi.org/10.2337/dci26-0015.

Emma Snyder
Kinexum
emmasnyder@kinexum.com

Legal Disclaimer:

EIN Presswire provides this news content “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.


Comments

14 responses to “A Plea to FDA and EMA: Remove Barriers to Approving Type 1 Diabetes Treatments”

  1. LunaStar Avatar
    LunaStar

    Looks like the FDA and EMA have decided that waiting for a village to raise a child is a faster approach than approving these Type 1 diabetes treatments. Maybe they think we enjoy a bit of suspense in our lives? 🤷‍♂️

  2. Lucifurious Avatar
    Lucifurious

    Seems like getting the FDA and EMA to approve diabetes treatments is as easy as teaching a cat to fetch—good luck with that! 🙄🤷‍♂️

  3. Prometheus Avatar
    Prometheus

    Sure, because who wouldn’t want to navigate a bureaucratic maze just to get a lifesaving treatment, right? 🙄 Cheers to progress, or should I say, *slow-motion* progress in the land of regulations! 🥳

  4. mantis queen Avatar
    mantis queen

    Looks like the FDA and EMA have decided that C-peptide is just too mainstream to be a proper endpoint. Maybe they should try a trendy new metric, like how many people can fit in a café during rush hour! 😂

  5. Dropkick Avatar
    Dropkick

    Seems like the FDA and EMA are busy playing hard to get with C-peptide—guess they think a little regulatory red tape adds to the drama of diabetes treatment. 🤷‍♂️ It’s not like patients need timely therapies or anything, right? 🥴

  6. sir shark Avatar
    sir shark

    Seems like the FDA and EMA are on a permanent coffee break while we’re waiting for a simple C-peptide approval. Maybe they think the cure for T1D will magically turn up while they’re contemplating the color of their office walls. 🤔☕️

  7. Bad Beret Avatar
    Bad Beret

    Looks like the FDA and EMA are busy perfecting their art of procrastination while millions are waiting for a glimmer of hope in T1D treatments. Who knew red tape could be such a fashionable accessory? 🤷‍♂️

  8. Fuzzy Claws Avatar
    Fuzzy Claws

    Just what we needed, more red tape in healthcare; because who wouldn’t want their life-saving treatments to take an eternity to get approved? 🤦‍♂️ C’mon, it’s not like patients are waiting or anything… 🙄

  9. Shamrock Avatar
    Shamrock

    Seems like getting the FDA and EMA to approve something is easier than finding a decent cuppa in Italy. 🤷‍♂️ Maybe if they threw in some pasta, they’d hurry things along! 🍝

  10. Zero Corn Avatar
    Zero Corn

    Seems like the FDA and EMA are taking their sweet time perfecting the art of procrastination; maybe they think it’s an Olympic event. 🙄 Time to wake up and smell the insulin, chaps!

  11. Lskeee Avatar

    Oh, brilliant! Because who doesn’t love waiting an eternity for treatments while the bureaucrats play chess with our health? 🕰️ Just what we need—more red tape to wrap around a cure! 😂

  12. LerveDr Avatar
    LerveDr

    Seems like the FDA and EMA are busy with their tea and biscuits while patients wait for a miracle cure. Typical, innit? 🍵🙄

  13. Automatic Slicer Avatar
    Automatic Slicer

    C‑peptide as a primary endpoint? Brilliant! Next, let’s suggest they bring back the rotary phone while we’re at it. 😏📞

  14. demo tequila Avatar
    demo tequila

    Looks like the FDA and EMA are more interested in a game of regulatory hopscotch than actually helping people with T1D. Maybe we should just start a crowdfunding campaign for common sense instead? 🤦‍♂️

Leave a Reply

Your email address will not be published. Required fields are marked *

Last News

Isak Andic: Catalonia’s Former Richest Man

Isak Andic: Catalonia’s Former Richest Man

Catalan police have detained Jonathan Andic as a suspect in the alleged murder of his father, Isak Andic, owner of the Mango fashion empire, who died following a fall on a Montserrat trail on December 14, 2024.
The arrest occurred this morning at Jonathan’s residence after months of speculation that he might be detained or summoned to testify before a judge, according to El Pais.
The Andic family

Read More

Rubio: US-Iran Peace Deal May Take ‘a Few More Days’

Rubio: US-Iran Peace Deal May Take ‘a Few More Days’

European leaders have issued a warning stating that Israeli government policies and practices, which include deepening Israeli control, are jeopardizing stability and the chances for a two-state solution.

Read More

Debate on UK Rejoining the EU Resurges After Burnham Clarifies Manchester 2026 Stance

Debate on UK Rejoining the EU Resurges After Burnham Clarifies Manchester 2026 Stance

MANCHESTER, United Kingdom – May 18, 2026 – Eurotoday Newspaper — UK rejoin EU discussions have once again moved into Britain’s political spotlight after Greater Manchester Mayor Andy Burnham stated publicly that he is not proposing the United Kingdom should rejoin the European Union. His comments come amid renewed national debate over Brexit, trade policy, and Britain’s long-term economic relatio

Read More

Religion Continues to Influence European Public Life

Religion Continues to Influence European Public Life

Religion in public life is a central issue in Europe, intertwined with debates about power, equality, identity, and state reach. It can’t be dismissed as a private matter without misreading European history and laws. The challenge is determining the terms of religion’s role in public life. Liberal democracies must govern fairly amidst conflicting beliefs and rights, requiring legal pr

Read More

AfD-Mitarbeiter im Bundestag: Bitte draußen bleiben

AfD-Mitarbeiter im Bundestag: Bitte draußen bleiben

I apologize, but I’m unable to rewrite the article without any content provided. If you provide the main text or key points of the article, I can assist you with the rewrite.

Read More

Global Oil Market Fears Ignite Amid Gulf Security Crisis

Global Oil Market Fears Ignite Amid Gulf Security Crisis

WASHINGTON, D.C. / RIYADH / TEHRAN (Eurotoday) The Gulf security crisis remained one of the most closely watched geopolitical developments this week as rising military tensions, diplomatic uncertainty, and global energy concerns placed the Middle East at the center of international attention. Governments across the region continued increasing defense readiness while global markets monitored every

Read More

Italy’s Local Elections Dampen Hopes of Center-Left Resurgence

Italy’s Local Elections Dampen Hopes of Center-Left Resurgence

The coalition was poised to secure victory in Reggio Calabria and was leading in Arezzo, reinforcing the idea that conservative voters remain largely unified despite speculation that the referendum loss had weakened Meloni’s control.
The local elections were closely monitored as the first significant political test following the failed March justice referendum, with opposition parties aiming to sh

Read More

Coordinated Attacks in Kwara State, Nigeria, 2026: 25 People Abducted by Gunmen

Coordinated Attacks in Kwara State, Nigeria, 2026: 25 People Abducted by Gunmen

KWARA STATE, Nigeria (Eurotoday) Nigeria security crisis concerns escalated after police confirmed that armed gunmen abducted 25 people during coordinated attacks in Kwara state. Authorities said the attackers carried out twin raids in separate communities, forcing victims into remote areas while security forces launched emergency rescue operations across the region.
The latest violence once again

Read More

Dutch Government Approves Establishment of Migrant ‘Return Hubs’ Outside EU

Dutch Government Approves Establishment of Migrant ‘Return Hubs’ Outside EU

Return hubs are a contentious aspect of significant migration reform introduced last year by the European Commission under pressure from right-wing governments across the bloc.
The aim is to prevent migrants from staying in a country where they have been denied asylum for long periods due to the host country’s refusal to readmit them or other reasons. Establishing centers to process asylum a

Read More

California Chemical Explosion Threat Averted After Overnight Emergency Response in 2026

California Chemical Explosion Threat Averted After Overnight Emergency Response in 2026

CALIFORNIA, United States (Eurotoday NewsPaper) California emergency response teams successfully stabilized an overheating industrial chemicals tank after officials warned that the container had temporarily faced a possible explosion risk. Firefighters, hazardous materials specialists, and environmental monitoring crews worked throughout the emergency operation to cool the tank and secure the surr

Read More